New patent filing secures composition of matter protection for AZD5904, a potent myeloperoxidase inhibitor in Conduit’s pipeline, unlocking up to 20 years of new IP runway and enabling enhanced ...
The new patents reflect combinations of Conduit's lead assets with existing therapies, identified through extensive AI-led analysis conducted in collaboration with Sarborg Limited (“Sarborg”). This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results